We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 18.3%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+18.3%
3 Year Est. Return
+55.27%
5 Year Est. Return
+61.88%
10 Year Est. Return
AUM
$498M
AUM Growth
+$47.5M
Cap. Flow
+$18.2M
Cap. Flow %
3.66%
Top 10 Hldgs %
36.91%
Holding
401
New
57
Increased
179
Reduced
114
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 5%
2 Healthcare 4.5%
3 Financials 3.75%
4 Communication Services 2.47%
5 Industrials 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
401
DELISTED
Celgene Corp
CELG
-6,167
Closed -$612K

Similar funds

Calton & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Calton & Associates held 401 positions worth $498M, up 11% from $450M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Calton & Associates deployed $18.2M of net new capital in Q4 2019, opening 57 new positions and adding to 179 existing holdings. Its largest new stake was Immunomedics Inc: 48,150 shares worth $1.02M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.79M trimmed.

  • Calton & Associates's largest Q4 2019 buy was Immunomedics Inc: 48,150 shares worth $1.02M.
  • Calton & Associates added most to State Street Health Care Select Sector SPDR ETF in Q4 2019, an estimated $2.24M increase.
  • Calton & Associates's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.79M.
  • Calton & Associates fully exited Invesco S&P 500 Equal Weight ETF in Q4 2019, selling an estimated $2.99M.
  • Calton & Associates's ten largest holdings make up 37% of its $498M portfolio in Q4 2019.
  • Calton & Associates opened 57 new positions and closed 43 in Q4 2019.
  • Calton & Associates's portfolio value rose 11% quarter-over-quarter to $498M.

Based on Calton & Associates's 13F filing for Q4 2019, filed 3 Feb 2020.